Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.

Michel, G; Boulad, F; Small, T N; Black, P; Heller, G; Castro-Malaspina, H; Childs, B H; Gillio, A P; Papadopoulos, E B; Young, J W; Kernan, N A; O'Reilly, R J

Michel, G; Boulad, F; Small, T N; Black, P; Heller, G; Castro-Malaspina, H; Childs, B H; Gillio, A P; Papadopoulos, E B; Young, J W; Kernan, N A; O'Reilly, R J.

Affiliation

Michel G; Memorial Sloan-Kettering Cancer Center, Department of Pediatrics, New York, New York 10021, USA.

Bone Marrow Transplant ; 20(2): 107-12, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9244412

Subject(s)

Bone Marrow Transplantation/adverse effects; Leukemia, Myeloid, Acute/therapy; Leukemic Infiltration/therapy; Skin/pathology; Adult; Female; Humans; Leukemia, Myeloid, Acute/pathology; Male; Recurrence; Retrospective Studies; Risk Assessment; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Skin / Leukemia, Myeloid, Acute / Bone Marrow Transplantation / Leukemic Infiltration Type of study: Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 1997 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links